The MAURO study: Multiple intervention and audit in renal diseases to optimize care

Journal of Nephrology

Volumn 21, Issue 1, 2008, Pages 20-22

  Zoccali, Carmine ^a   Leonardis, Daniela ^a   Enia, Giuseppe ^a   Postorino, Maurizio ^a   Mallamaci, Francesca ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM PHOSPHATE; PHOSPHATE BINDING AGENT;

AGED; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM METABOLISM; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HEART FUNCTION; HUMAN; HYPERTENSION; INTENSIVE CARE; INTERVENTION STUDY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MINERAL METABOLISM; OUTCOMES RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PHOSPHATE METABOLISM; PROCESS OPTIMIZATION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; EVIDENCE BASED MEDICINE; PRACTICE GUIDELINE;

EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; KIDNEY FAILURE, CHRONIC; MEDICAL AUDIT; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43249131482     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Hayward RS. Clinical practice guidelines on trial. CMAJ. 1997;156:1725-1727.
2. De Nicola L, Minutolo R, Chiodini P, et al; for the Target Blood Pressure Levels in Chronic Kidney Disease (TABLE in CKD) study group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69:538-545.
3. Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Ann Intern Med. 2005;142:342-351.